Profiles of cytokine mRNAs in the skin and lymph nodes of SENCAR mice treated epicutaneously with dibenzo[a,I]pyrene or dimethylbenz[a]anthracene reveal a direct correlation between carcinogen-induced contact hypersensitivity and epidermal hyperplasia
Gp. Casale et al., Profiles of cytokine mRNAs in the skin and lymph nodes of SENCAR mice treated epicutaneously with dibenzo[a,I]pyrene or dimethylbenz[a]anthracene reveal a direct correlation between carcinogen-induced contact hypersensitivity and epidermal hyperplasia, MOL CARCINO, 27(2), 2000, pp. 125-140
The potent carcinogenicity of dibenzo[a,l]pyrene (DB[a,l]P) in mouse skin i
s associated with an inflammatory response and a striking epidermal hyperpl
asia. The mechanism of these tissue responses is not known. However, a rece
nt study has shown DB[a,l]P to be a contact sensitizer. In view of the prog
rammed expression of cytokines during induction of contact hypersensitivity
(CHS) and elicitation of CHS reactions, we analyzed cytokine mRNAs in trea
ted skin and draining lymph nodes of SENCAR mice, at selected times after a
single, epicutaneous application of DB[a,l]P or dimethylbenz[a]anthracene
(DMBA), a substantially weaker carcinogen and a weaker contact sensitizer t
han DB[a,l]P. Cytokine mRNAs were quantified by first-strand DNA synthesis
with reverse transcriptase (RT) and DNA amplification by the polymerase cha
in reaction (PCR). Histopathology of treated skin was determined in the sam
e experiments. Time-response profiles of interferon (IFN)gamma and interleu
kin (IL)2 in the DLN and IL1 beta, IL10, tumor necrosis factor (TNF) alpha,
and IL4 mRNAs in the skin of mice treated with 200 nmol of DB[a,l]P were i
n remarkable agreement with established profiles in mice treated with conve
ntional contact sensitizers, e.g., oxazolone or dinitrochlorobenzene. Stron
g upregulation of DLN IFN gamma mRNA coupled with little change in IL 2 mRN
A suggested a CD8(+) T-cell response characteristic of CHS induction. Coord
inate expression of epidermal IL1 beta, TNF alpha, and IL10 mRNAs, 24 h aft
er DB[a,l]P treatment, was also characteristic of CHS induction. IL1 beta a
nd IL10 are upregulated by allergens and not by chemical irritants. Time-re
sponse profiles of epidermal IL1 beta, TNF alpha, IL10, and IL4 mRNAs, 3-14
d after DB[a,l]P treatment, corresponded with expression of these cytokines
during elicitation of CHS reactions. Epidermal IL4 is specifically upregul
ated during CHS reactions. Cytokine mRNA responses were dose-dependent (50,
100, and 200 nmol of DB[a,l]P) and markedly weaker in animals treated with
400 nmol of DMBA. Significantly, the intensity of epidermal hyperplasia co
rrelated with the strength of the cytokine mRNA signals in DLN and skin. In
conclusion, our data support carcinogen-specific CHS as a mechanism by whi
ch the very potent carcinogen DB[a,l]P induces epidermal hyperplasia, a req
uirement for tumor promotion in mouse skin. (C) 2000 Wiley-Liss, Inc.